Hemant Surgical Industries Ltd Company Summary

194
(-4.83%)
Jul 23, 2024|03:40:00 PM

Hemant Surgical Industries Ltd Summary

Hemant Surgical Industries Ltd was originally incorporated as Hemant Surgical Industries Private Limited dated March 27, 1989, by ROC, Maharashtra, Mumbai. Subsequently, Company was converted into a public limited company and the name of Company was changed to Hemant Surgical Industries Limited vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai. The Company manufacture, import, assemble and market a comprehensive portfolio of medical equipments and disposables. Its product offerings cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables. In addition, the Company is providing services for maintenance and in running of dialysis centres.The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd. Japan. Later in year 1999, it started the operations by expanding manufacturing plant at Achhad, Maharashtra and is currently manufacturing products like Dialysis solution (liquid and Powder) used in dialysis, Hot and Cold Sterilant used for cleaning dialyzer, Purified water used in rinsing and cleaning of dialysis machines and sanitizer. Assembly Unit II situated at Atgaon is used in various medical devices like Nebulizers, Oxygen Concentrator, Air Mattress, Digital Thermometer, Pulse Oximeters, ECG Electrodes, Dialyzer which are sold under the Brand Name Aero Plus. Assembly Unit III at Bhiwandi is used in products like Intravenous Infusion Set, ECG Machines, Ultrasound Machines, Paramonitor, Ventilator etc. Later, in year 2022, the Company got into a distribution agreement with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India, with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set. The Company was appointed as sole agent of SWS Hemodialysis Care Co. Ltd. China to sell and do maintenance of SWS-4000A hemodialysis machines in West India. It signed distribution agreement with Hemant Phillipines Inc. for supply in renal care equipment, medical devices and consumables for marketing the same in Philippines, with Zoncare Bio-medical Electronics Co., Ltd for radiology and assembly of critical care products like Ultrasound Machine.The Company is planning to come out with an initial public offer consisting of issuing upto 27,60,000 Equity Shares.

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.